Our capital expenditures for the three and six months ended June 30, 2008 and 2007 were as follows (in thousands):
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
| 2008 | 2007 | 2008 | 2007 | |||||||||||||
| Type | ||||||||||||||||
| Recurring | $ | 7,495 | $ | 7,921 | $ | 14,692 | $ | 14,146 | ||||||||
| Reimbursements | (881 | ) | (872 | ) | (2,041 | ) | (872 | ) | ||||||||
| Net recurring | 6,614 | 7,049 | 12,651 | 13,274 | ||||||||||||
Corporate(1) | 3,425 | 3,219 | 7,339 | 9,198 | ||||||||||||
EBITDA-enhancing(2) | 11,089 | 14,619 | 25,010 | 25,010 | ||||||||||||
Development(3) | 19,446 | 8,843 | 40,627 | 20,579 | ||||||||||||
| Net Total Capital Expenditures | $ | 40,574 | $ | 33,730 | $ | 85,627 | $ | 68,061 | ||||||||
| (1) | Corporate primarily includes capital expenditures for information technology systems and equipment. |
| (2) | EBITDA-enhancing capital expenditures generally represent unusual or non-recurring capital items and/or major renovations. |
| (3) | Development capital expenditures primarily relate to the facility expansion and de novo development program. |